European Pharmaceutical Review

AUGUST 31, 2023

Overcoming challenges in patient safety, manufacturing and supply of radiopharmaceuticals As clinical trials progress and the first results are published, companies’ best candidates will emerge in the next five years. Hospital staff must also be protected from radiation while handling the agent.

Food and Drug Administration 79

Food and Drug Administration Manufacturing Safety Transportation 79

Pharma Marketing Network

MARCH 25, 2022

80% provide transportation 1. The FDA has studied the importance of caregivers to drug development and regulatory decision-making. Caregiver observations of the patient experience over the progression of the disease may inform the safety and efficacy of a particular therapeutic. 98% provide emotional support 1. Sunny White.

Pharma 98

Pharma Education Transportation Training 98

pharmaphorum

OCTOBER 26, 2022

There are many challenges in the development of therapies for rare diseases due to several unique factors, including small target patient populations, lack of long-term safety and efficacy data or natural history data, and often complex administration, dosing, and patient monitoring requirements,” Chiesi says.

Patients 82

Patients Pharma Consulting Transportation 82

PM360

SEPTEMBER 15, 2022

Cure” put me on a path to work across a network of incredibly smart, passionate, and well-meaning stakeholders to connect dots, create forums for sharing ideas, drive patient-centered approaches, and eliminate lost-in-translation moments. Fortunately, the industry is increasing its discussions around improving patient inclusion and DEI.

Patients 98

Patients Healthcare Healthcare Marketing 98

Clarify Health

MAY 27, 2022

The US Food and Drug Administration (FDA) recently announced new draft guidance for life science companies on increasing diversity and inclusion in clinical trials to improve enrollments of underrepresented racial and ethnic populations. FDA Commissioner Robert M.

FDA 52

FDA Food and Drug Administration Recruitment Transportation 52

Clarify Health

MAY 27, 2022

The US Food and Drug Administration (FDA) recently announced new draft guidance for life science companies on increasing diversity and inclusion in clinical trials to improve enrollments of underrepresented racial and ethnic populations. FDA Commissioner Robert M.

FDA 52

FDA Food and Drug Administration Recruitment Transportation 52

Clarify Health

DECEMBER 13, 2022

Prior to him walking in, the sponsor and pharmacy already have a holistic view of his patient journey and understand factors affecting his lifestyle, such as whether he buys cigarettes or lacks transportation. Question: What’s the FDA’s approach to unlocking the full promise of real-world evidence?

Recruitment 52

Recruitment Retail Patients Education 52